|

OBESIAL: A Prospective Interventional Real-world Study of a Multidisciplinary Obesity Management Programme

RECRUITINGN/ASponsored by University of Health Sciences, Algeria
Actively Recruiting
PhaseN/A
SponsorUniversity of Health Sciences, Algeria
Started2026-01-22
Est. completion2028-01-23
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07779343

Summary

The OBESIAL (Obesity Structured Intervention in Algeria) study aims to evaluate the clinical, metabolic, and organisational impact of a structured multidisciplinary obesity care pathway implemented under real-world conditions.

Eligibility

Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* Adults aged 18-65 years
* BMI ≥30 kg/m²
* Written informed consent obtained prior to enrolment

Exclusion Criteria:

* Refusal to participate or inability to adhere to follow-up procedures
* Pregnancy at enrolment
* Severe or unstable comorbidities compromising safety or participation, including:

  * Recent acute cardiovascular event (\<60 days)
  * Active malignancy
  * Severe unstable organic disease
* Previous bariatric surgery
* Obesity pharmacotherapy within the previous 90 days
* Known contraindication to planned therapeutic options
* Severe unstable psychiatric disorders
* Genetic obesity or obesity secondary to uncontrolled endocrine disease

Exclusion Criteria During Follow-up

* Pregnancy occurring during follow-up
* Initiation of chronic treatment associated with weight gain

Conditions5

DiabetesObesity Adult OnsetObesity Difficult Airway Airway ManagementObesity Type 2 Diabetes MellitusObesity and Cardiovascular Risk

Interventions1

Semaglutide (Wegovy) weekly injection

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.